Study finds AI tool MySTIRisk effectively identifies high-risk STI subgroups
March 5th 2024A recent study revealed the effectiveness of the AI tool MySTIRisk in pinpointing high-risk subgroups for HIV and other sexually transmitted infections, shedding light on improved risk assessment and testing accessibility.
Dexamethasone dosage in preterm births: Efficacy found from 5-mg dose
March 5th 2024A recent study compared the efficacy and safety of 5-mg versus 6-mg doses of dexamethasone in preventing neonatal respiratory distress syndrome in preterm births, shedding light on dosage optimization for improved neonatal outcomes.
Risk of graft loss in pregnant kidney transplant recipients
March 5th 2024A study examines the association between donor types and obstetrical and graft morbidity risks among pregnant kidney transplant recipients, revealing increased short- and long-term graft loss risk from pregnancy after deceased donor kidney transplant compared to living donor kidney transplant.
Study: Amniocentesis doesn't increase hepatitis B transmission risk in infants
March 4th 2024A recent study finds that, contrary to previous concerns, amniocentesis does not heighten the risk of mother-to-child transmission of hepatitis B virus among infants following a standardized immunoprophylaxis schedule.
Assessing the impact of oxytocin use on postpartum hemorrhage
March 1st 2024A recent study reveals that while oxytocin dosage correlates with a slight uptick in postpartum hemorrhage (PPH) risk, the use of oxytocin augmentation doesn't significantly increase PPH or blood loss when compared to patients with similar obstetric profiles.
Study: Antibiotic therapy reduces intraamniotic inflammation in second trimester idiopathic bleeding
March 1st 2024A recent study revealed the efficacy of antibiotic therapy in reducing intraamniotic inflammation among patients experiencing idiopathic bleeding in the second trimester of pregnancy, shedding light on potential management strategies for this condition.
Placental oxygenation's link to fetal brain volumes
February 29th 2024Discover how transverse relaxation time mapping, a sensitive magnetic resonance imaging-based technique, unveils the relationship between placental oxygenation and fetal brain development, shedding light on potential biomarkers for assessing fetal well-being.
Unveiling metabolic markers of Candida albicans infection
February 27th 2024Discover how metabolomics sheds light on potential biomarkers for early detection and treatment of Candida albicans-induced vulvovaginal candidiasis, offering crucial insights into the pathogenesis of this prevalent inflammatory condition.
Understanding patient perspectives on fetal malpresentation management
February 26th 2024A recent investigation sheds light on patient preferences and concerns regarding external cephalic version versus cesarean section for managing fetal malpresentation, revealing gaps in counseling and the desire for more information.
Demystifying bacterial vaginosis: Understanding, treatment, and breaking stigmas
February 26th 2024Misunderstandings surrounding bacterial vaginosis can delay treatment, but advancements such as XACIATO offer effective solutions, emphasizing the importance of open communication and continued research for comprehensive women's health care.
FDA approves enmetazobactam for treatment of cUTIs
February 23rd 2024Enmetazobactam (Exblifep; Orchid Pharma) gains FDA approval for treating complicated urinary tract infections in adults after demonstrating superiority over piperacillin-tazobactam in clinical cure and microbiological eradication in a global phase 3 trial.
Alabama Supreme Court ruling halts IVF treatment at UAB
February 22nd 2024Following a landmark decision regarding the status of embryos, the University of Alabama at Birmingham has suspended in vitro fertilization services, sparking concerns over reproductive rights and health care access as experts grapple with the legal aftermath.
Study reveals link between opioid dosage and spontaneous preterm birth risk
February 21st 2024Recent research highlighted an association between the total dose of prescribed opioids during pregnancy and the heightened risk of spontaneous preterm birth, emphasizing the need for judicious opioid use in pain management for expectant mothers.